(Munich, November 17, 2020) For many companies, Covid-19 means standstill, but for some a hard sprint. The UK company Intersurgical manufactures medical devices for respiratory support and because of the pandemic suddenly had to increase its capacity significantly. In this emergency situation, KraussMaffei has proved to be a flexible and reliable partner.

When Covid-19 became an issue at the beginning of 2020, Charles Bellm, Managing Director of Intersurgical, had no idea that the illness would have such a massive impact on their business. By February, things were different: the first factory had already closed, and more and more governments and hospitals were contacting Intersurgical to secure deliveries of large a quantities of the highly specialized articles for respiratory support "We could have increased our production twenty-fold, and it still wouldn't have been enough," remembers Bellm.

However, the production capacity was massively increased: with over 3,000 employees worldwide, 704 joined the teams during the course of the crisis, along with numerous new KraussMaffei injection molding machines being put into operation for Covid-19 relevant products.

For Intersurgical, the Covid-19 sprint was possible only because the company has always attached importance to quality and reliable human interaction. Employees who have been working at the company for decades were able to integrate the new colleagues well, and with the delivery of additional systems, there was confidence in the partnership with KraussMaffei, which has existed since 1996. Charles Bellm summarizes the events of the past eight months: "In this crisis, we have learned how to work efficiently, and also who we can rely on."